Novartis Is “On A Mission” To Address Unmet Hypertension Needs
Novartis is targeting the 30 mil.-35 mil. untreated hypertension patients in the U.S. and is relaunching a compliance program to target existing patients.
Novartis is targeting the 30 mil.-35 mil. untreated hypertension patients in the U.S. and is relaunching a compliance program to target existing patients.